in health care, economic analyses encompass issues that range far beyond costs and benefits to complex issues of regulation, ethics, and equity, as the above themes demonstrate. Many different sources of information will need to be brought together efficiently to enable informed decision making and to determine how to move forward with integrating genomic medicine in a way that maximizes patient benefit while at the same time making the most economic sense.
The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
"1 Introduction and Overview."
The Economics of Genomic Medicine: Workshop Summary.
Washington, DC: The National Academies Press, 2013.
Please select a format: